Natsuhara Y, Oka S, Kaneda K, Kato Y, Yano I
Department of Bacteriology, Osaka City University Medical School, Japan.
Cancer Immunol Immunother. 1990;31(2):99-106. doi: 10.1007/BF01742373.
Multiple intravenous injections (30 micrograms, ten times) in ICR mice of trehalose dimycolate and glucose monomycolate from Nocardia rubra, containing C36-48 mycolic acids, showed a prominent antitumor effect on a subcutaneously implanted sarcoma-180, an allogeneic sarcoma of mice with a significant granuloma formation in lungs, spleen and liver. On the other hand, mycoloyl glycolipids other than glucose monomycolate and trehalose dimycolate, such as mannose or fructose mycolate, showed no significant activity for tumor regression or granuloma formation in mice. Trehalose dimycolate and glucose monomycolate from N. rubra, and glucose monomycolate with C56-60 mycolic acids from Rhodococcus terrae also showed a distinctive priming activity for tumor necrosis factor (TNF), when lipopolysaccharide from Escherichia coli was administered as an eliciting agent. The TNF activity in the sera of mice was abrogated almost completely by anti-(murine TNF alpha) antibody with protein-A-agarose. Again in contrast, mannose and fructose mycolate from N. rubra and glucose monomycolate with C30-34 mycolic acids from Rhodococcus equi did not show such activities in mice. Meth-A, a syngeneic fibrosarcoma of BALB/c mice, was less sensitive to administration of glycolipids than sarcoma-180. These results indicated that the existence of a glucose or trehalose molecule was necessary for the expression of immunomodifying activities among various mycoloyl glycolipids differing in carbohydrate structure. However, since the administration of lipopolysaccharide was essentially required as an eliciting agent for the induction of TNF, while no eliciting agent was required for the antitumor activities, TNF does not seem to contribute directly to the antitumor activities of mycoloyl glycolipids in our systems. There was, however, a parallel structure-activity relationship among granuloma-forming, antitumor and TNF-priming activities, indicating that the structures of both the carbohydrate moiety and the mycoloyl residues influenced an initial step, such as macrophage activation, commonly and profoundly.
将含有C36 - 48分枝菌酸的红色诺卡氏菌海藻糖二霉菌酸酯和葡萄糖单霉菌酸酯以多次静脉注射(30微克,共十次)的方式注入ICR小鼠体内,结果显示其对皮下植入的肉瘤-180(一种小鼠同种异体肉瘤)具有显著的抗肿瘤作用,且在肺、脾和肝脏中形成了明显的肉芽肿。另一方面,除葡萄糖单霉菌酸酯和海藻糖二霉菌酸酯之外的其他霉菌酰糖脂,如甘露糖或果糖霉菌酸酯,对小鼠肿瘤消退或肉芽肿形成均无显著活性。当以大肠杆菌脂多糖作为诱导剂时,红色诺卡氏菌的海藻糖二霉菌酸酯和葡萄糖单霉菌酸酯,以及土地红球菌含有C56 - 60分枝菌酸的葡萄糖单霉菌酸酯,对肿瘤坏死因子(TNF)也表现出独特的启动活性。用蛋白A - 琼脂糖偶联的抗(鼠TNFα)抗体几乎完全消除了小鼠血清中的TNF活性。同样与之形成对比的是,红色诺卡氏菌的甘露糖和果糖霉菌酸酯以及马红球菌含有C30 - 34分枝菌酸的葡萄糖单霉菌酸酯在小鼠体内未表现出此类活性。BALB/c小鼠的同基因纤维肉瘤Meth - A对糖脂给药的敏感性低于肉瘤-180。这些结果表明,在碳水化合物结构不同的各种霉菌酰糖脂中,葡萄糖或海藻糖分子的存在对于免疫调节活性的表达是必要的。然而,由于脂多糖的给药本质上是诱导TNF所必需的诱导剂,而抗肿瘤活性则不需要诱导剂,因此在我们的实验体系中,TNF似乎并未直接参与霉菌酰糖脂的抗肿瘤活性。不过,肉芽肿形成、抗肿瘤和TNF启动活性之间存在平行的构效关系,这表明碳水化合物部分和霉菌酰残基的结构共同且深刻地影响了诸如巨噬细胞激活等初始步骤。